- Home
- ASMB vs PROP Comparison
ASMB vs PROP Comparison
Compare ASMB & PROP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASMB
- PROP
- Stock Information
- Founded
- ASMB 2005
- PROP 2001
- Country
- ASMB United States
- PROP United States
- Employees
- ASMB N/A
- PROP N/A
- Industry
- ASMB Biotechnology: Pharmaceutical Preparations
- PROP Investment Bankers/Brokers/Service
- Sector
- ASMB Health Care
- PROP Finance
- Exchange
- ASMB Nasdaq
- PROP Nasdaq
- Market Cap
- ASMB 97.8M
- PROP 115.3M
- IPO Year
- ASMB 2010
- PROP N/A
- Fundamental
- Price
- ASMB $15.21
- PROP $7.54
- Analyst Decision
- ASMB Buy
- PROP
- Analyst Count
- ASMB 2
- PROP 0
- Target Price
- ASMB $35.00
- PROP N/A
- AVG Volume (30 Days)
- ASMB 42.2K
- PROP 128.0K
- Earning Date
- ASMB 11-07-2024
- PROP 01-01-0001
- Dividend Yield
- ASMB N/A
- PROP N/A
- EPS Growth
- ASMB N/A
- PROP N/A
- EPS
- ASMB N/A
- PROP N/A
- Revenue
- ASMB $28,326,000.00
- PROP $1,545,792.00
- Revenue This Year
- ASMB $282.16
- PROP $5,586.66
- Revenue Next Year
- ASMB N/A
- PROP $244.90
- P/E Ratio
- ASMB N/A
- PROP N/A
- Revenue Growth
- ASMB N/A
- PROP N/A
- 52 Week Low
- ASMB $9.12
- PROP $5.70
- 52 Week High
- ASMB $19.93
- PROP $16.08
- Technical
- Relative Strength Index (RSI)
- ASMB 46.95
- PROP 43.49
- Support Level
- ASMB $13.20
- PROP $6.69
- Resistance Level
- ASMB $16.75
- PROP $8.03
- Average True Range (ATR)
- ASMB 1.05
- PROP 0.59
- MACD
- ASMB -0.08
- PROP -0.06
- Stochastic Oscillator
- ASMB 53.03
- PROP 41.46
About ASMB Assembly Biosciences Inc.
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
About PROP Prairie Operating Co.
Prairie Operating Co develops and operates bitcoin mining scaled-up facilities using natural gas to power the operations. It generates substantially all its revenue through cryptocurrency, which it earns through mining activities.